Inventor · disambiguated record
F. Timothy Guilford
Also filed as: GUILFORD F T · GUILFORD F TIMOTHY
6 granted patents·18 pending applications·73 citations·filing 2001–2012
85Inventor score
Top patents by PatentIndex Score
24 records- 0191US8147869B2Liposome-encapsulated glutathione for oral administrationGUILFORD F TIMOTHY·Filed 2011·Granted Apr 3, 2012·14 cites·1 claims
- 0288US8679530B2Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal, prepartion, for reversal and prevention of oxidation of cholesterol and of low density lipoproteinGUILFORD F TIMOTHY·Filed 2006·Granted Mar 25, 2014·10 cites·1 claims
- 0388US8252325B2Liposome-encapsulated glutathione for oral administrationGUILFORD F TIMOTHY·Filed 2012·Granted Aug 28, 2012·8 cites·1 claims
- 0487US8349359B2Liposomal formulation for oral administration of glutathione (reduced)YOUR ENERGY SYSTEMS LLC·Filed 2005·Granted Jan 8, 2013·10 cites·16 claims
- 0585US8114913B1Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with DHEA for the treatment of smallpoxGUILFORD F TIMOTHY·Filed 2009·Granted Feb 14, 2012·7 cites·3 claims
- 0680US6534540B2Combination and method of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitorFiled 2001·Granted Mar 18, 2003·24 cites·11 claims
- 0761US2010166846A1Management of myoclonus with oral liposomal reduced glutathioneGUILFORD F TIMOTHY·Filed 2009·Application pending·0 cites
- 0859US2007053970A1Liposomal formulation for oral administration of glutathione (reduced) and/or methylcobalamine for diseases related to glutathione deficiency and deficiency of the methionine remethylation pathwayGUILFORD F T·Filed 2006·Application pending·0 cites
- 0953US2008131496A1Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non histamine related inflammatory skin changesGUILFORD F TIMOTHY·Filed 2007·Application pending·0 cites
- 1052US2009068253A1Method for the treatment of infection with hhv-6 virus and the amelioration of symptoms related to virus using liposomal encapsulation for delivery of reduced glutathioneGUILFORD F TIMOTHY·Filed 2006·Application pending·0 cites
- 1151US2007077258A1ADMINISTRATION OF GLUTATHIONE (REDUCED) VIA INTRAVENOUS OR ENCAPSULATED IN LIPOSOME FOR THE AMELIORATION OF TNF-alpha EFFECTS AND FLU-LIKE VIRAL SYMPTOMS AND TREATMENT AND PREVENTION OF VIRUSGUILFORD F T·Filed 2006·Application pending·0 cites
- 1251US2009047340A1Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesisGUILFORD F TIMOTHY·Filed 2007·Application pending·0 cites
- 1350US2010291196A1Method of treatment of autism spectrum disorder with liposomal reduced glutathioneGUILFORD F TIMOTHY·Filed 2010·Application pending·0 cites
- 1450US2012087994A1Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with dhea for the treatment of smallpoxGUILFORD F TIMOTHY·Filed 2011·Application pending·0 cites
- 1549US2004022873A1Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as anthrax, smallpox or radiation and for vaccination prophylaxis, and use in combination with DHEA for the treatment of smallpox and other virusesFiled 2002·Application pending·0 cites
- 1646US2012219616A1LIPOSOMAL REDUCED GLUTATHIONE AND l-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESISGUILFORD F TIMOTHY·Filed 2012·Application pending·0 cites
- 1745US2003162829A1Combination of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitorFiled 2003·Application pending·0 cites
- 1842US2002169195A1Combination and method of treatment of cancer utilizing a COX-2 inhibitor and an HMG-CoA inhibitor and cystine to enhance glutathioneFiled 2002·Application pending·0 cites
- 1942US2002137785A1Inflammatory mechanism modulator composition and methods with anti-asthmatic propertiesFiled 2002·Application pending·0 cites
- 2042US2011020436A1Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changesGUILFORD F TIMOTHY·Filed 2010·Application pending·0 cites
- 2142US2002182585A1Combination and method using EDTA, cystine, zinc and selenium for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacyFiled 2002·Application pending·0 cites
- 2241US2002132781A1Combination and method of treatment of cancer utilizing a COX-2 inhibitor and A 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG-CoA) reductase inhibitorFiled 2001·Application pending·0 cites
- 2340US2002187130A1Adjuvant immune therapy in the treatment of solid tumors through modulation of signaling pathways following engagement of humoral and cell mediated responsesFiled 2001·Application pending·0 cites
- 2440US2010316700A1Systemic administration of liposomal reduced glutathione for the decorporation of radioactive materials and non-radioactive mercuryGUILFORD F TIMOTHY·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →